Tocilizumab, also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer... Wikipedia

 

 

 

Manufacturer's Website: Actemra                                                                                                             Average retail cost: $1,945/month

 

Search Terms: Actemra, tocilizumab, intravenous, immunosuppressive, rheumatoid arthritis, systemic juvenile idiopathic arthritis